Tyra biosciences to present at the 2024 cantor global healthcare conference

Carlsbad, calif. , sept. 11, 2024 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, announced today its participation at the 2024 cantor global healthcare conference.

TYRA Ratings Summary

TYRA Quant Ranking